Science

Ravi Parikh: Predicting immunotherapy response in non-small cell lung cancer

Ravi Parikh/chibe.upenn.edu

Dec 20, 2024, 14:19

Ravi Parikh: Predicting immunotherapy response in non-small cell lung cancer

Ravi Parikh, Director of Human-Algorithm Collaboration Lab at Winship Cancer Institute of Emory University, shared a post on X about a recent paper by him and colleagues published in JCO Clinical Cancer Informatics:

“Check out our JCO Clinical Cancer Informatics paper on the development and real-world/clinical trial validation of Deep Learning CT biomarker to predict immunotherapy response in non-small cell lung cancer! Presented at ASCO24.”

Real-World and Clinical Trial Validation of a Deep Learning Radiomic Biomarker for PD-(L)1 Immune Checkpoint Inhibitor Response in Advanced Non–Small Cell Lung Cancer

Authors: Chiharu Sako et al.

More posts featuring Ravi Parikh.

ASCO24 cancer Chiharu Sako Chong Duan George Simon Hugo Aerts JCO Clinical Cancer Informatics Kevin Maresca non small cell lung cancer NSCLC OncoDaily Oncology Petr Jordan Ravi Parikh Sean Kent Taly Gilat Schmidt

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer

Black History Month 2025: Honoring Contributions to Oncology